UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Quarterly Period Ended December 31, 2004
OR
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 |
For the transition period from to .
Commission File Number 000-31081
TRIPATH TECHNOLOGY INC.
(Exact name of registrant as specified in its charter)
| Delaware | 77-0407364 | |
| (State or other jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) |
2560 Orchard Parkway
San Jose, California 95131
(Address of Principal Executive Office including (Zip Code)
(408) 750-3000
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (Exchange Act) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes x No ¨
50,420,190 shares of the Registrants common stock were outstanding as of January 31, 2005.
| PART I. Financial Information |
1 | |||||
| Item 1. Financial Statements | 1 | |||||
| Condensed Consolidated Balance Sheets as of December 31, 2004 (unaudited) and September 30, 2004 |
1 | |||||
| 2 | ||||||
| 3 | ||||||
| Notes to Condensed Interim Consolidated Financial Statements |
4 | |||||
| Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations | 13 | |||||
| Risk Factors | 18 | |||||
| Item 3. Quantitative and Qualitative Disclosures about Market Risk | 26 | |||||
| Item 4. Controls and Procedures | 26 | |||||
| PART II. Other Information |
28 | |||||
| Item 1. Legal Proceedings | 28 | |||||
| Item 6. Exhibits | 31 | |||||
| Signatures | 32 | |||||
| Exhibit Index | 33 | |||||
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
| December 31, 2004 |
September 30, 2004 |
|||||||
| ASSETS |
||||||||
| Current assets: |
||||||||
| Cash, cash equivalents and restricted cash |
$ | 3,932 | $ | 7,339 | ||||
| Accounts receivable, net |
615 | 1,019 | ||||||
| Inventories, net |
3,625 | 3,780 | ||||||
| Prepaid expenses and other current assets |
374 | 212 | ||||||
| Total current assets |
8,546 | 12,350 | ||||||
| Property and equipment, net |
1,429 | 1,674 | ||||||
| Other assets |
129 | 123 | ||||||
| Total assets |
$ | 10,104 | $ | 14,147 | ||||
| LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ | 1,932 | $ | 2,908 | ||||
| Current portion of capital lease obligations |
461 | 664 | ||||||
| Current portion of deferred rent |
276 | 266 | ||||||
| Accrued expenses |
871 | 764 | ||||||
| Deferred distributor revenue |
730 | 823 | ||||||
| Total current liabilities |
4,270 | 5,425 | ||||||
| Long term liabilities |
479 | 571 | ||||||
| Commitments and contingencies (see Note 10) |
||||||||
| Stockholders equity: |
||||||||
| Common stock, $0.001 par value, 100,000,000 shares authorized; 50,233,101 and 50,043,158 shares issued and outstanding at December 31, 2004 (unaudited) and September 30, 2004 respectively |
50 | 49 | ||||||
| Additional paid-in capital |
199,396 | 199,333 | ||||||
| Deferred stock-based compensation |
(54 | ) | (95 | ) | ||||
| Accumulated deficit |
(194,037 | ) | (191,136 | ) | ||||
| Total stockholders equity |
5,355 | 8,151 | ||||||
| Total liabilities and stockholders equity |
$ | 10,104 | $ | 14,147 | ||||
The accompanying notes are an integral part of these condensed interim consolidated financial statements.
1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
Unaudited
| Three Months Ended December 31, |
||||||||
| 2004 |
2003 |
|||||||
| Revenue |
$ | 1,618 | $ | 4,126 | ||||
| Cost of revenue |
1,195 | 2,769 | ||||||
| Gross profit |
423 | 1,357 | ||||||
| Operating expenses: |
||||||||
| Research and development |
1,901 | 1,669 | ||||||
| Selling, general and administrative |
1,428 | 1,082 | ||||||
| Total operating expenses |
3,329 | 2,751 | ||||||
| Loss from operations |
(2,906 | ) | (1,394 | ) | ||||
| Interest and other income, net |
5 | 8 | ||||||
| Net loss |
$ | (2,901 | ) | $ | (1,386 | ) | ||
| Basic and diluted net loss per share |
$ | (0.06 | ) | $ | (0.03 | ) | ||
| Number of shares used in computing basic and diluted net loss per share |
48,267 | 43,853 | ||||||
The accompanying notes are an integral part of these condensed interim consolidated financial statements.
2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Unaudited
| Three Months Ended December 31, |
||||||||
| 2004 |
2003 |
|||||||
| Cash flows from operating activities: |
||||||||
| Net loss |
$ | (2,901 | ) | $ | (1,386 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
| Depreciation and amortization |
249 | 294 | ||||||
| Deferred Rent |
(63 | ) | 52 | |||||
| Allowance for doubtful accounts |
| (6 | ) | |||||
| Provision for slow moving, excess and obsolete inventory |
| 243 | ||||||
| Stock-based compensation |
41 | 46 | ||||||
| Changes in assets and liabilities: |
||||||||
| Accounts receivable |
404 | (101 | ) | |||||
| Inventories |
155 | (1,781 | ) | |||||
| Prepaid expenses and other assets |
(168 | ) | (106 | ) | ||||
| Accounts payable |
(976 | ) | 1,559 | |||||
| Accrued expenses |
107 | (72 | ) | |||||
| Deferred distributor revenue |
(93 | ) | 387 | |||||
| Net cash used in operating activities |
(3,245 | ) | (871 | ) | ||||
| Cash flows from investing activities: |
||||||||
| Purchase of property and equipment |
(4 | ) | (201 | ) | ||||
| Net cash used in investing activities |
(4 | ) | (201 | ) | ||||
| Cash flows from financing activities: |
||||||||
| Proceeds from issuance of common stock under ESPP and upon exercise of options |
64 | 304 | ||||||
| Proceeds from issuance of common stock upon exercise of warrants |
| 1,366 | ||||||
| Principal payments on capital lease obligations |
(222 | ) | (74 | ) | ||||
| Net cash provided by (used in) financing activities |
(158 | ) | 1,596 | |||||
| Net increase (decrease) in cash and cash equivalents |
(3,407 | ) | 524 | |||||
| Cash, cash equivalents, and restricted cash, beginning of period |
7,339 | 9,088 | ||||||
| Cash, cash equivalents, and restricted cash, end of period |
$ | 3,932 | $ | 9,612 | ||||
| Non-cash financing activity: |
||||||||
| Property and equipment acquired by capital lease |
$ | | $ | 317 | ||||
The accompanying notes are an integral part of these condensed interim consolidated financial statements.
3
Notes to Condensed Interim Consolidated Financial Statements
(Unaudited)
1. Basis of Presentation
The unaudited condensed interim consolidated financial statements included herein have been prepared by Tripath Technology Inc. (the Company) in accordance with accounting principles generally accepted in the United States of America and reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary to state fairly the Companys financial position, results of operations and cash flows for the periods presented. These interim financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Companys Transition Report on Form 10-K/T for the transition period ended September 30, 2004. The results of operations for the three months ended December 31, 2004 are not necessarily indicative of the results to be expected for any subsequent quarter or for the entire year.
On November 14, 2004, Tripaths Board of Directors approved a change in the Companys fiscal year end from December 31 to September 30, effective as of September 30, 2004.
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates, and such differences may be material to the financial statements.
The unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned Japanese subsidiary, which was incorporated in January 2001. All significant intercompany balances and transactions have been eliminated in consolidation. The U.S. dollar is the functional currency for the Companys Japanese wholly-owned subsidiary. Assets and liabilities that are not denominated in the functional currency are remeasured into U.S. dollars and the resulting gains or losses are included in Interest and other income, net. Such gains or losses have not been material for any period presented.
The Companys consolidated financial statements have been prepared on the basis of a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred substantial losses and has experienced negative cash flow since inception and has an accumulated deficit of $194 million at December 31, 2004.
Beginning in August 2001, the Company instituted programs to reduce expenses including reducing headcount from 144 employees at the end of July 2001 to 63 employees at the end of December 2004 and reducing employees salaries by 10%. In September 2002 the Company relocated its headquarters which reduced rent expense and canceled its D&O policy which reduced insurance expense. These actions resulted in significant cost savings in 2003. The Company reduced its cash used in operating activities from approximately $13 million in 2002 to approximately $4 million in 2003. However, for the nine months ended September 30, 2004, cash used in operating activities increased to $9.1 million, and for the three months ended December 31, 2004, cash used in operating activities was $3.2 million.
During 2004, warrants were exercised which resulted in the Company receiving proceeds totaling approximately $2.3 million. In addition, in August 2004 we raised $5 million through financing. At December 31, 2004, the Company had working capital of $4.3 million, including cash of $3.9 million.
The Company is aware that its existing working capital at December 31, 2004 may not be sufficient to meet its operating, working capital, investing and financing requirements for the next twelve months. The Company has not made any adjustment to its consolidated financial statements as a result of the outcome of the uncertainty described above.
The Company will need to raise additional funds to finance its activities through public or private equity or debt financings, the formation of strategic partnerships or alliances with other companies or through bank borrowings with existing or new banks. The Company may not be able to obtain additional funds on terms that would be favorable to the Company and its stockholders, or at all. In such instance, the Company will take measures to reduce its operating expenses, such as reducing headcount or canceling selected research and development projects. Without sufficient capital to fund its operations, the Company will no longer be able to continue as a going concern. The Company believes, based on its current cash balance as well as its ability to implement the aforementioned measures, if needed, that the Company will have liquidity sufficient to meet its operating, working capital and financing needs for the next twelve months and perhaps beyond. The Companys long-term prospects are dependent upon obtaining sufficient financing as needed to fund current working capital needs and future growth, and ultimately on achieving profitability.
4
2. Revenue recognition
The Company recognizes revenue in accordance with Securities and Exchange Commission Staff Accounting Bulletin No. 104 (SAB 104), Revenue Recognition. The Company recognizes revenue when all of the following criteria are met: 1) there is persuasive evidence that an arrangement exists, 2) delivery of goods has occurred, 3) the sales price is fixed or determinable, and 4) collectibility is reasonably assured. The following policies apply to the Companys major categories of revenue transactions.
Sales to OEM Customers: Under the Companys standard terms and conditions of sale, title and risk of loss transfer to the customer at the time product is shipped to the customer, FOB shipping point, and revenue is recognized accordingly. The Company accrues the estimated cost of post-sale obligations, including basic product warranties or returns, based on historical experience. The Company has experienced minimal warranty or other returns to date.
Sales to Distributors: The Company provides its distributors certain incentives such as stock rotation, price protection, and other offerings. As a result of these incentives, the Company generally defers recognition of revenue until such time that the distributor sells product to its customer based upon receipt of point-of-sale reports from the distributor. In limited circumstances, revenue may be recognized when sold to a distributor if the distributor acknowledges in writing that there is no right of return and the sale otherwise meets the SAB 104 criteria.
3. Net loss per share
Basic net loss per share is computed by dividing the net loss attributable to common stockholders for the period by the weighted average number of common stock outstanding during the period. Diluted net loss per share is computed based on the weighted average number of common stock and dilutive potential common stock outstanding. The calculation of diluted net loss per share excludes potential common stock if the effect is anti-dilutive. Potential common stock consists of incremental common stock issuable upon the exercise of stock options and common stock issuable upon the exercise of common stock warrants.
Total potential common stock of 12,312,000 and 11,852,000 shares were not included in the diluted net loss per share calculation for the periods ended December 31, 2004 and 2003, respectively, because to do so would be anti-dilutive.
The following table sets forth the computation of basic and diluted net loss per share for the periods presented (in thousands, except per share amounts):
| Three Months Ended December 31, |
||||||||
| 2004 |
2003 |
|||||||
| Numerator: |
||||||||
| Net loss |
$ | (2,901 | ) | $ | (1,386 | ) | ||
| Denominator: |
||||||||
| Weighted average common stock |
48,267 | 43,853 | ||||||
| Basic and diluted net loss per share |
$ | (0.06 | ) | $ | (0.03 | ) | ||
5
4. Deferred stock-based compensation
The Company recognized deferred stock-based compensation in connection with certain employee stock option grants and the issuance of restricted stock. The deferred stock-based compensation related to the employee stock option grants is being amortized over the vesting periods of the related options, generally four years, using an accelerated basis while the deferred stock-based compensation related to the issuance of restricted stock is being amortized over two years on a straight line basis. The fair value per share used to calculate deferred stock-based compensation was derived by reference to the share quoted price. Future compensation charges are subject to reduction for any employee who terminates employment prior to such employees option vesting date.
The Company has granted options to purchase shares of common stock to consultants in exchange for services. The Company determined the value of the options granted to consultants based on the Black-Scholes option pricing model.
The following table sets forth, for each of the periods presented, the deferred stock-based compensation recorded and the amortization of deferred stock-based compensation (in thousands):
| Three Months Ended December 31, | ||||||
| 2004 |
2003 | |||||
| Deferred stock-based compensation |
$ | | $ | | ||
| Amortization of deferred stock-based compensation |
$ | 41 | $ | 46 | ||
Unamortized deferred stock-based compensation at December 31, 2004 and September 30, 2004 was $54,000 and $ 95,000 respectively.
5. Accounting for stock-based compensation
The Company accounts for its stock-based compensation plans under the recognition and measurement principles of APB Opinion No. 25, Accounting for Stock Issued to Employees, and related Interpretations. No stock-based employee compensation cost is reflected in net income for the periods ended December 31, 2004 and 2003, as all options granted under those plans had an exercise price that was at least equal to the market value of the underlying common stock on the date of grant.
The following table illustrates the effect on net loss and loss per share as if the Company had applied the fair value recognition provisions of FASB Statement No. 123, Accounting for Stock-Based Compensation to stock-based employee compensation.
| Three Months Ended December 31, |
||||||||
| 2004 |
2003 |
|||||||
| Net loss applicable to common stockholders, as reported |
$ | (2,901 | ) | $ | (1,386 | ) | ||
| Total stock-based employee compensation expense (benefit) included in the net loss, determined under the recognition and measurement principles of APB Opinion No. 25, net of related tax effects |
41 | 46 | ||||||
| Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects |
(1,035 | ) | (547 | ) | ||||
| Pro forma net loss applicable to common stockholders |
$ | (3,895 | ) | $ | (1,887 | ) | ||
| Loss per share: |
||||||||
| Basic - as reported |
$ | (0.06 | ) | $ | (0.03 | ) | ||
| Basic pro forma |
$ | (0.08 | ) | $ | (0.04 | ) | ||
6
6. Cash, cash equivalents and restricted cash